Publication | Open Access
Effect of once‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial
27
Citations
24
References
2018
Year
Semaglutide treatment did not compromise the counterregulatory glucagon response during experimental hypoglycaemia in people with T2D.
| Year | Citations | |
|---|---|---|
Page 1
Page 1